InvestorsHub Logo
Followers 27
Posts 672
Boards Moderated 0
Alias Born 07/26/2017

Re: None

Wednesday, 07/26/2017 11:46:29 AM

Wednesday, July 26, 2017 11:46:29 AM

Post# of 693169
So a lot of comments have been made good and bad about LL's participation in a Forbes article. Her participation should be viewed as a positive simply because her opinion was sought out above all others in this field. Her hands are tied right now with regard DCVAX but make no mistake, her invitation was down to DCVAX's imminent datalock and hopefully FDA approval. The time of immunotherapy and it's advancement is upon us and I believe that although DCVAX does not offer a cure for all, it's approval will pave the way for the advancement of these types of cancer therapies. Chemo and radium will be consigned to dust eventually as the scientific world know this is not the answer.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News